Development and validation of a method for quantitative determination of valsartan in human plasma by liquid chromatography-tandem mass spectrometry

Journal of Pharmaceutical and Biomedical Analysis

Volumn 43, Issue 5, 2007, Pages 1769-1774

  Koseki, Nozomu ^a   Kawashita, Hiroto ^a   Hara, Hisanori ^a   Niina, Miyuki ^a   Tanaka, Makoto ^a   Kawai, Ryosei ^a   Nagae, Yusuke ^a   Masuda, Naoki ^a  

^a NOVARTIS PHARMA K K   (Japan)

Author keywords

Human pharmacokinetics; Inter subject variability; Liquid chromatography tandem mass spectrometry; Matrix effects; Valsartan

Indexed keywords

CGP 48791; UNCLASSIFIED DRUG; VALSARTAN;

ACCURACY; ANALYTIC METHOD; ARTICLE; CALIBRATION; CONTROLLED STUDY; DEVICE; DRUG BLOOD LEVEL; HUMAN; HUMAN EXPERIMENT; HUMAN TISSUE; LIQUID CHROMATOGRAPHY; NORMAL HUMAN; PRIORITY JOURNAL; QUANTITATIVE ASSAY; REPRODUCIBILITY; SINGLE DRUG DOSE; SOLID PHASE EXTRACTION; TANDEM MASS SPECTROMETRY; VALIDATION PROCESS;

ANTIHYPERTENSIVE AGENTS; CHROMATOGRAPHY, LIQUID; DRUG STABILITY; HUMANS; MOLECULAR STRUCTURE; REFERENCE STANDARDS; REPRODUCIBILITY OF RESULTS; SENSITIVITY AND SPECIFICITY; TANDEM MASS SPECTROMETRY; TEMPERATURE; TETRAZOLES; VALINE;

EID: 33947382605     PISSN: 07317085     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jpba.2006.12.030     Document Type: Article

References (14)

1. Markham A., and Goa K.L. Drugs 54 (1997) 299-311
2. Waldmeier F., Flesch G., Muller P., Winkler T., Kriemler H.P., Buhlmayer P., and de Gasparo M. Xenobiotica 27 (1997) 59-71
3. Flesch G., Muller Ph., and Lloyd P. Eur. J. Clin. Phamacol. 52 (1997) 115-120
4. Brunner L.A., Powell M.L., Degen P., and Flesch G. Lab. Robot Automat. 6 (1994) 171-179
5. Sioufi A., Marfil F., and Godbillon J. J. Liq. Chromatogr. 17 (1994) 2179-2186
6. Daneshtalab N., Lewanczuk R.Z., and Jamali F. J. Chromatogr. B 766 (2002) 345-349
7. Macek J., Kl'i{dotless}ma J., and Ptacek P. J. Chromatogr. B 832 (2006) 169-172
8. Taylor P.J. Clin. Biochem. 38 (2005) 328-334
9. Koseki N., Nakashima A., Nagae Y., and Masuda N. Rapid Commun. Mass Spectrom. 20 (2006) 733-740
10. Steinborner S., and Henion J. Anal. Chem. 71 (1999) 2340-2345
11. Zhang H., and Henion J. Anal. Chem. 71 (1999) 3955-3964
12. Zweigenbaum J., and Henion J. Anal. Chem. 72 (2000) 2446-2454
13. Guidance for Industry: Bioanalytical Method Validation, US Department of Health and Human Services, Food and Drug Administration, Center for Drug Evaluation and Research (CDER) and Center for Veterinary Medicine (CVM), May 2001, http://www.fda.gov/cder/guidance/index.htm.
14. Kitamura R., Matsuoka K., Matsushima E., and Kawaguchi Y. J. Chromatogr. B 754 (2001) 113-119